| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Medicine, University of Adelaide, The Queen Elizabeth Hospital, Woodville, South Australia 5011
The induction of apoptosis of tumor cells by the colonic fermentation product butyrate is thought to be an important mechanism in protection against colorectal cancer. Because a major action of butyrate is to inhibit histone deacetylase (leading to chromatin relaxation and altered gene expression), butyrate may induce apoptosis by derepression of specific cell death genes. Here we show that butyrate and trichostatin A (a more selective inhibitor of histone deacetylase) induce the same program of apoptosis in Jurkat lymphoid and LIM 1215 colorectal cancer cell lines that is strictly dependent on new protein synthesis (within 10 h) and that leads to the conversion of the proenzyme form of caspase-3 to the catalytically active effector protease (within 16 h) and apoptotic death (within 24 h). Cells primed with a low concentration of butyrate that itself did not induce activation of caspase-3 or apoptosis were, nevertheless, rendered highly susceptible to induction of apoptosis by staurosporine (an agent that has recently been shown to act by causing mitochondrial release of cytochrome c). Synergy between butyrate and staurosporine was due to the presence of a factor in the cytosol of butyrate-primed cells which enhanced over 7-fold the activation of caspase-3 induced by the addition of cytochrome c and dATP to isolated cytosol. We propose that changes at the level of chromatin structure, induced by a physiological substance butyrate, lead to the expression of a protein that facilitates the pathway by which mitochondria activate caspase-3 and trigger apoptotic death of lymphoid and colorectal cancer cells.
1 This study was supported by grants from the Australian Research Council and the University of Adelaide. V. M. was supported by a scholarship from the Government of the Canary Islands.
2 To whom requests for reprints should be addressed. Phone: 61 8 8222 7344; Fax: 61 8 8222 6042.
Received 1/29/97. Accepted 7/ 3/97.
This article has been cited by other articles:
|
|
 |
|
  Y. Zhang, M. Tuzova, Z.-X. J. Xiao, W. W. Cruikshank, and D. M. Center Pro-IL-16 Recruits Histone Deacetylase 3 to the Skp2 Core Promoter through Interaction with Transcription Factor GABP J. Immunol., January 1, 2008; 180(1): 402 - 408. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. R. Fantin and V. M. Richon Mechanisms of Resistance to Histone Deacetylase Inhibitors and Their Therapeutic Implications Clin. Cancer Res., December 15, 2007; 13(24): 7237 - 7242. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. F Rezende, L. F Stoppiglia, K. L A Souza, A. Negro, F. Langone, and A. C Boschero Ciliary neurotrophic factor promotes survival of neonatal rat islets via the BCL-2 anti-apoptotic pathway J. Endocrinol., October 1, 2007; 195(1): 157 - 165. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Jiang, C. W. Bell, and D. S. Pisetsky The Relationship between Apoptosis and High-Mobility Group Protein 1 Release from Murine Macrophages Stimulated with Lipopolysaccharide or Polyinosinic-Polycytidylic Acid J. Immunol., May 15, 2007; 178(10): 6495 - 6503. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. K. Le Leu, I. L. Brown, Y. Hu, T. Morita, A. Esterman, and G. P. Young Effect of dietary resistant starch and protein on colonic fermentation and intestinal tumourigenesis in rats Carcinogenesis, February 1, 2007; 28(2): 240 - 245. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. C. Dowdy, S. Jiang, X. C. Zhou, X. Hou, F. Jin, K. C. Podratz, and S.-W. Jiang Histone deacetylase inhibitors and paclitaxel cause synergistic effects on apoptosis and microtubule stabilization in papillary serous endometrial cancer cells. Mol. Cancer Ther., November 1, 2006; 5(11): 2767 - 2776. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Bauer-Marinovic, S. Florian, K. Muller-Schmehl, H. Glatt, and G. Jacobasch Dietary resistant starch type 3 prevents tumor induction by 1,2-dimethylhydrazine and alters proliferation, apoptosis and dedifferentiation in rat colon Carcinogenesis, September 1, 2006; 27(9): 1849 - 1859. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q. Xia, J. Sung, W. Chowdhury, C.-l. Chen, N. Hoti, S. Shabbeer, M. Carducci, and R. Rodriguez Chronic Administration of Valproic Acid Inhibits Prostate Cancer Cell Growth In vitro and In vivo. Cancer Res., July 15, 2006; 66(14): 7237 - 7244. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Wang, Q.-Y. He, R. W.-Y. Sun, C.-M. Che, and J.-F. Chiu Gold(III) Porphyrin 1a Induced Apoptosis by Mitochondrial Death Pathways Related to Reactive Oxygen Species Cancer Res., December 15, 2005; 65(24): 11553 - 11564. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Ogawa, T. Hayashi, M. Tokunou, K. Nakachi, J. E. Trosko, C.-C. Chang, and N. Yorioka Suberoylanilide Hydroxamic Acid Enhances Gap Junctional Intercellular Communication via Acetylation of Histone Containing Connexin 43 Gene Locus Cancer Res., November 1, 2005; 65(21): 9771 - 9778. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Wu, Y. Cheng, B. A. G. Jonsson, A. Nilsson, and R.-D. Duan Acid sphingomyelinase is induced by butyrate but does not initiate the anticancer effect of butyrate in HT29 and HepG2 cells J. Lipid Res., September 1, 2005; 46(9): 1944 - 1952. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. K. Le Leu, I. L. Brown, Y. Hu, A. R. Bird, M. Jackson, A. Esterman, and G. P. Young A Synbiotic Combination of Resistant Starch and Bifidobacterium lactis Facilitates Apoptotic Deletion of Carcinogen-Damaged Cells in Rat Colon J. Nutr., May 1, 2005; 135(5): 996 - 1001. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. W. Vance, S. Carreira, G. Brosch, and C. R. Goding Tbx2 Is Overexpressed and Plays an Important Role in Maintaining Proliferation and Suppression of Senescence in Melanomas Cancer Res., March 15, 2005; 65(6): 2260 - 2268. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. J. Li and T. H. Elsasser Butyrate-induced apoptosis and cell cycle arrest in bovine kidney epithelial cells: Involvement of caspase and proteasome pathways J Anim Sci, January 1, 2005; 83(1): 89 - 97. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Kurita-Ochiai, S. Seto, and K. Ochiai Role of Cell-Cell Communication in Inhibiting Butyric Acid-Induced T-Cell Apoptosis Infect. Immun., October 1, 2004; 72(10): 5947 - 5954. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. F. Toth, T. A. Knoch, M. Wachsmuth, M. Frank-Stohr, M. Stohr, C. P. Bacher, G. Muller, and K. Rippe Trichostatin A-induced histone acetylation causes decondensation of interphase chromatin J. Cell Sci., August 15, 2004; 117(18): 4277 - 4287. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. H. Ho, R. E. Ruffin, C. Murgia, L. Li, S. A. Krilis, and P. D. Zalewski Labile Zinc and Zinc Transporter ZnT4 in Mast Cell Granules: Role in Regulation of Caspase Activation and NF-{kappa}B Translocation J. Immunol., June 15, 2004; 172(12): 7750 - 7760. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. D. Zhang, S. K. Gillespie, J. M. Borrow, and P. Hersey The histone deacetylase inhibitor suberic bishydroxamate regulates the expression of multiple apoptotic mediators and induces mitochondria-dependent apoptosis of melanoma cells Mol. Cancer Ther., April 1, 2004; 3(4): 425 - 435. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. A. Alrefai, S. Tyagi, R. Gill, S. Saksena, C. Hadjiagapiou, F. Mansour, K. Ramaswamy, and P. K. Dudeja Regulation of butyrate uptake in Caco-2 cells by phorbol 12-myristate 13-acetate Am J Physiol Gastrointest Liver Physiol, February 1, 2004; 286(2): G197 - G203. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Gozzini, E. Rovida, P. Dello Sbarba, S. Galimbert, and V. Santini Butyrates, as a Single Drug, Induce Histone Acetylation and Granulocytic Maturation: Possible Selectivity on Core Binding Factor-Acute Myeloid Leukemia Blasts Cancer Res., December 15, 2003; 63(24): 8955 - 8961. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Kurita-Ochiai, S. Amano, K. Fukushima, and K. Ochiai Cellular Events Involved in Butyric Acid-Induced T Cell Apoptosis J. Immunol., October 1, 2003; 171(7): 3576 - 3584. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Catley, E. Weisberg, Y.-T. Tai, P. Atadja, S. Remiszewski, T. Hideshima, N. Mitsiades, R. Shringarpure, R. LeBlanc, D. Chauhan, et al. NVP-LAQ824 is a potent novel histone deacetylase inhibitor with significant activity against multiple myeloma Blood, October 1, 2003; 102(7): 2615 - 2622. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Peart, K. M. Tainton, A. A. Ruefli, A. E. Dear, K. A. Sedelies, L. A. O'Reilly, N. J. Waterhouse, J. A. Trapani, and R. W. Johnstone Novel Mechanisms of Apoptosis Induced by Histone Deacetylase Inhibitors Cancer Res., August 1, 2003; 63(15): 4460 - 4471. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. K. Le Leu, I. L. Brown, Y. Hu, and G. P. Young Effect of resistant starch on genotoxin-induced apoptosis, colonic epithelium, and lumenal contents in rats Carcinogenesis, August 1, 2003; 24(8): 1347 - 1352. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. H McIntosh, M. Noakes, P. J Royle, and P. R Foster Whole-grain rye and wheat foods and markers of bowel health in overweight middle-aged men Am. J. Clinical Nutrition, April 1, 2003; 77(4): 967 - 974. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Henderson, M. Mizzau, G. Paroni, R. Maestro, C. Schneider, and C. Brancolini Role of Caspases, Bid, and p53 in the Apoptotic Response Triggered by Histone Deacetylase Inhibitors Trichostatin-A (TSA) and Suberoylanilide Hydroxamic Acid (SAHA) J. Biol. Chem., March 28, 2003; 278(14): 12579 - 12589. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. YASUI, N. OUE, S. ONO, Y. MITANI, R. ITO, and H. NAKAYAMA Histone Acetylation and Gastrointestinal Carcinogenesis Ann. N.Y. Acad. Sci., March 1, 2003; 983(1): 220 - 231. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. De Schepper, H. Bruwiere, T. Verhulst, U. Steller, L. Andries, W. Wouters, M. Janicot, J. Arts, and J. Van heusden Inhibition of Histone Deacetylases by Chlamydocin Induces Apoptosis and Proteasome-Mediated Degradation of Survivin J. Pharmacol. Exp. Ther., February 1, 2003; 304(2): 881 - 888. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F M Ruemmele, S Schwartz, E G Seidman, S Dionne, E Levy, and M J Lentze Butyrate induced Caco-2 cell apoptosis is mediated via the mitochondrial pathway Gut, January 1, 2003; 52(1): 94 - 100. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Legros, A. Lombes, P. Frachon, and M. Rojo Mitochondrial Fusion in Human Cells Is Efficient, Requires the Inner Membrane Potential, and Is Mediated by Mitofusins Mol. Biol. Cell, December 1, 2002; 13(12): 4343 - 4354. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Batova, L.-e. Shao, M. B. Diccianni, A. L.Y. T. Tanaka, A. Rephaeli, A. Nudelman, and J. Yu The histone deacetylase inhibitor AN-9 has selective toxicity to acute leukemia and drug-resistant primary leukemia and cancer cell lines Blood, October 16, 2002; 100(9): 3319 - 3324. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. V. Blagosklonny, R. Robey, D. L. Sackett, L. Du, F. Traganos, Z. Darzynkiewicz, T. Fojo, and S. E. Bates Histone Deacetylase Inhibitors All Induce p21 but Differentially Cause Tubulin Acetylation, Mitotic Arrest, and Cytotoxicity Mol. Cancer Ther., September 1, 2002; 1(11): 937 - 941. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Lovborg, J. Wojciechowski, R. Larsson, and J. Wesierska-Gadek Action of a Novel Anticancer Agent, CHS 828, on Mouse Fibroblasts: Increased Sensitivity of Cells Lacking Poly (ADP-Ribose) Polymerase-1 Cancer Res., August 1, 2002; 62(15): 4206 - 4211. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Hu, J. Martin, R. Le Leu, and G.P. Young The colonic response to genotoxic carcinogens in the rat: regulation by dietary fibre Carcinogenesis, July 1, 2002; 23(7): 1131 - 1137. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R.K. Le Leu, Y. Hu, and G.P. Young Effects of resistant starch and nonstarch polysaccharides on colonic luminal environment and genotoxin-induced apoptosis in the rat Carcinogenesis, May 1, 2002; 23(5): 713 - 719. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Tsubaki, V. Hwa, S. M. Twigg, and R. G. Rosenfeld Differential Activation of the IGF Binding Protein-3 Promoter by Butyrate in Prostate Cancer Cells Endocrinology, May 1, 2002; 143(5): 1778 - 1788. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. F. Hinnebusch, S. Meng, J. T. Wu, S. Y. Archer, and R. A. Hodin The Effects of Short-Chain Fatty Acids on Human Colon Cancer Cell Phenotype Are Associated with Histone Hyperacetylation J. Nutr., May 1, 2002; 132(5): 1012 - 1017. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Merezak, M. Reichert, C. Van Lint, P. Kerkhofs, D. Portetelle, L. Willems, and R. Kettmann Inhibition of Histone Deacetylases Induces Bovine Leukemia Virus Expression In Vitro and In Vivo J. Virol., April 16, 2002; 76(10): 5034 - 5042. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. K. H. Pflum, J. K. Tong, W. S. Lane, and S. L. Schreiber Histone Deacetylase 1 Phosphorylation Promotes Enzymatic Activity and Complex Formation J. Biol. Chem., December 7, 2001; 276(50): 47733 - 47741. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. X. Cao, I. Mohuiddin, F. Ece, D. J. McConkey, and W. R. Smythe Histone Deacetylase Inhibitor Downregulation of bcl-xl Gene Expression Leads to Apoptotic Cell Death in Mesothelioma Am. J. Respir. Cell Mol. Biol., November 1, 2001; 25(5): 562 - 568. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. N. Laribee and M. J. Klemsz Loss of PU.1 Expression Following Inhibition of Histone Deacetylases J. Immunol., November 1, 2001; 167(9): 5160 - 5166. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. L. Leng, K. S. Leeding, P. R. Gibson, and L. A. Bach Insulin-like growth factor-II renders LIM 2405 human colon cancer cells resistant to butyrate-induced apoptosis: a potential mechanism for colon cancer cell survival in vivo Carcinogenesis, October 1, 2001; 22(10): 1625 - 1631. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Burgess, S. Pavey, R. Warrener, L.-J. K. Hunter, T. J. Piva, E. A. Musgrove, N. Saunders, P. G. Parsons, and B. G. Gabrielli Up-Regulation of p21WAF1/CIP1 by Histone Deacetylase Inhibitors Reduces Their Cytotoxicity Mol. Pharmacol., October 1, 2001; 60(4): 828 - 837. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. T. Wu, S. Y. Archer, B. Hinnebusch, S. Meng, and R. A. Hodin Transient vs. prolonged histone hyperacetylation: effects on colon cancer cell growth, differentiation, and apoptosis Am J Physiol Gastrointest Liver Physiol, March 1, 2001; 280(3): G482 - G490. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W.-G. Zhu, R. R. Lakshmanan, M. D. Beal, and G. A. Otterson DNA Methyltransferase Inhibition Enhances Apoptosis Induced by Histone Deacetylase Inhibitors Cancer Res., February 1, 2001; 61(4): 1327 - 1333. [Abstract] [Full Text]
|
|
|
|
|
|
W. J. Magner, A. L. Kazim, C. Stewart, M. A. Romano, G. Catalano, C. Grande, N. Keiser, F. Santaniello, and T. B. Tomasi Activation of MHC Class I, II, and CD40 Gene Expression by Histone Deacetylase Inhibitors J. Immunol., December 15, 2000; 165(12): 7017 - 7024. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. G. Heerdt, M. A. Houston, J. M. Mariadason, and L. H. Augenlicht Dissociation of Staurosporine-induced Apoptosis from G2-M Arrest in SW620 Human Colonic Carcinoma Cells: Initiation of the Apoptotic Cascade Is Associated with Elevation of the Mitochondrial Membrane Potential ({{Delta}}{{psi}}m) Cancer Res., December 1, 2000; 60(23): 6704 - 6713. [Abstract] [Full Text]
|
|
|
|
 |
|
 A. Q. Truong-Tran, R. E. Ruffin, and P. D. Zalewski Visualization of labile zinc and its role in apoptosis of primary airway epithelial cells and cell lines Am J Physiol Lung Cell Mol Physiol, December 1, 2000; 279(6): L1172 - L1183. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Mariadason, G. A. Corner, and L. H. Augenlicht Genetic Reprogramming in Pathways of Colonic Cell Maturation Induced by Short Chain Fatty Acids: Comparison with Trichostatin A, Sulindac, and Curcumin and Implications for Chemoprevention of Colon Cancer Cancer Res., August 1, 2000; 60(16): 4561 - 4572. [Abstract] [Full Text]
|
|
|
|
|
|
A. McGinty, Y.-W. E. Chang, A. Sorokin, D. Bokemeyer, and M. J. Dunn Cyclooxygenase-2 Expression Inhibits Trophic Withdrawal Apoptosis in Nerve Growth Factor-differentiated PC12 Cells J. Biol. Chem., April 14, 2000; 275(16): 12095 - 12101. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Chai, A. Evdokiou, G.P. Young, and P.D. Zalewski Involvement of p21Waf1/Cip1 and its cleavage by DEVD-caspase during apoptosis of colorectal cancer cells induced by butyrate Carcinogenesis, January 1, 2000; 21(1): 7 - 14. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. C. Sambucetti, D. D. Fischer, S. Zabludoff, P. O. Kwon, H. Chamberlin, N. Trogani, H. Xu, and D. Cohen Histone Deacetylase Inhibition Selectively Alters the Activity and Expression of Cell Cycle Proteins Leading to Specific Chromatin Acetylation and Antiproliferative Effects J. Biol. Chem., December 3, 1999; 274(49): 34940 - 34947. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Vanden Berghe, K. De Bosscher, E. Boone, S. Plaisance, and G. Haegeman The Nuclear Factor-kappa B Engages CBP/p300 and Histone Acetyltransferase Activity for Transcriptional Activation of the Interleukin-6 Gene Promoter J. Biol. Chem., November 5, 1999; 274(45): 32091 - 32098. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Giuliano, M. Lauricella, G. Calvaruso, M. Carabillo, S. Emanuele, R. Vento, and G. Tesoriere The Apoptotic Effects and Synergistic Interaction of Sodium Butyrate and MG132 in Human Retinoblastoma Y79 Cells Cancer Res., November 1, 1999; 59(21): 5586 - 5595. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. BERNHARD, M. J. AUSSERLECHNER, M. TONKO, M. LÖFFLER, B. L. HARTMANN, A. CSORDAS, and R. KOFLER Apoptosis induced by the histone deacetylase inhibitor sodium butyrate in human leukemic lymphoblasts FASEB J, November 1, 1999; 13(14): 1991 - 2001. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. Bordonaro, J. M. Mariadason, F. Aslam, B. G. Heerdt, and L. H. Augenlicht Butyrate-induced Apoptotic Cascade in Colonic Carcinoma Cells: Modulation of the {beta}-Catenin-Tcf Pathway and Concordance with Effects of Sulindac and Trichostatin A but not Curcumin Cell Growth Differ., October 1, 1999; 10(10): 713 - 720. [Abstract] [Full Text]
|
|
|
|
|
|
S. Ruller, C. Stahl, G. Kohler, B. Eickhoff, J. Breder, M. Schlaak, and J. van der Bosch Sensitization of Tumor Cells to Ribotoxic Stress-induced Apoptotic Cell Death: A New Therapeutic Strategy Clin. Cancer Res., October 1, 1999; 5(10): 2714 - 2725. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. D. Glick, S. L. Swendeman, D. C. Coffey, R. A. Rifkind, P. A. Marks, V. M. Richon, and M. P. La Quaglia Hybrid Polar Histone Deacetylase Inhibitor Induces Apoptosis and CD95/CD95 Ligand Expression in Human Neuroblastoma Cancer Res., September 1, 1999; 59(17): 4392 - 4399. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-Y. Fan, J. Zhang, R. Barhoumi, R. C. Burghardt, N. D. Turner, J. R. Lupton, and R. S. Chapkin Antagonism of CD95 signaling blocks butyrate induction of apoptosis in young adult mouse colonic cells Am J Physiol Cell Physiol, August 1, 1999; 277(2): C310 - C319. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. L. Ric |
